Document is current
Any future updates will be listed below
-
Authors
Siedlecki, Jakob http://orcid.org/0000-0002-0279-4823
Priglinger, Siegfried
- License Information
-
More Information
Article History
Received: 1 May 2024
Revised: 6 May 2024
Accepted: 6 June 2024
First Online: 21 June 2024
Competing interests
: S. Priglinger: Novartis Pharma GmbH advisory board/honoraria. Pharma Allergan advisory board/honoraria. Zeiss advisory board/honoraria. BVI advisory board/honoraria. Bayer advisory board/honoraria. Alcon advisory board/honoraria. B&L advisory board/honoraria. Allergan advisory board/honoraria. Roche advisory board/honoraria, Oertli honoraria. J. Siedlecki: Novartis Pharma GmbH advisory board/honoraria. Abbvie/Pharm-Allergan advisory board/honoraria. Bayer advisory board/honoraria. Heidelberg Engineering honoraria. Roche advisory board/honoraria. Apellis advisory board/honoraria.
Free to read: This content has been made available to all.
